openPR Logo
Press release

Cathepsin Inhibitors Market Key Developments, Footprint with Top Players Hoffmann-La Roche AG, Merck Sharp & Dohme, Virobay, LEO Pharma

07-01-2019 01:13 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent Market Insights

Cathepsin Inhibitors

Cathepsin Inhibitors

Cathepsins are a group of lysosomal proteases (enzymes that degrades protein), found in all animals and other organisms, and perform a key role in cellular protein turnover. Cathepsin family includes serine proteases, aspartic proteases, and cysteine proteases. The aspartyl protease class is composed of cathepsins D and E. The cysteine protease class comprises cathepsins B, L, H, K, S, and O. Cathepsin G includes serine protease class. Currently, there are no approved cathepsin inhibitors in the market, however various research and development activities are under process for the development of novel cathepsin inhibitors for treatment of various conditions such as cancer, traumatic brain injury, Ebola infection, and others.

Cathepsin Inhibitors Market Drivers

Various key players in the market are conducting clinical trials to gain approval for cathepsin inhibitors, which are under development phase and are expected to gain approval in the near future.

For instance, Merck Sharp & Dohme Corp.’s product, Odanacatib, also known as MK-0822, is under Phase 2 clinical trial. MK-0822 is a cathepsin K inhibitor under development for the treatment of postmenopausal women with osteoporosis. Hence, presence of novel products in the pipeline is expected to significantly support growth of the cathepsin inhibitors market during the forecast period.

Furthermore, high prevalence of diseases for which cathepsin inhibitors are being developed may rise demand for such novel treatment approaches in the near future. For instance, according to the data published by Centers of Disease Control and Prevention in 2017, traumatic brain injury (TBI) is a major cause of death and disability in the U.S. TBIs contribute to about 30% of all injury deaths. 153 people in the U.S. die per day, from injuries that include TBI.

Request A Sample Copy:
https://www.coherentmarketinsights.com/insight/request-sample/2306

Cathepsin Inhibitors Market Regional Analysis

North America cathepsin inhibitors market is expected to hold a dominant position in the global cathepsin inhibitors market, owing to the high prevalence of disease such as cancer, which will increase demand for novel cancer treatment approaches such as cathepsin inhibitors in region.

For instance, according to the data published by National Cancer Institute, it was estimated that in 2018, around 1,735,350 new cases of cancer will be diagnosed in the U.S. and around 609,640 people will die from the disease.

Europe cathepsin inhibitors market is also expected to show a significant growth during the forecast period, owing to frequent research and development activities by key players for the development of new cathepsin inhibitors in the region. For instance, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, is developing RO5459072, a cathepsin S inhibitor, on the immune response to a gluten challenge in volunteers with celiac disease.

Cathepsin Inhibitors Market Key Players

Key players operating in global cathepsin inhibitors market include F. Hoffmann-La Roche AG, Merck Sharp & Dohme Corp., Virobay Inc., LEO Pharma, and others.

Cathepsin Inhibitors Market Taxonomy:

The global cathepsin inhibitors market is segmented on the basis of product type, indication, distribution channel, and region

By Product Type-

Cathepsin S Inhibitors
Cathepsin K Inhibitors
Cathepsin B Inhibitors
Cathepsin L Inhibitors
Others
By Indication-

Cancer
Traumatic Brain Injury
Ebola Infection
Others

Get PDF Brochure of This Business Report:
https://www.coherentmarketinsights.com/insight/request-pdf/2306

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cathepsin Inhibitors Market Key Developments, Footprint with Top Players Hoffmann-La Roche AG, Merck Sharp & Dohme, Virobay, LEO Pharma here

News-ID: 1792677 • Views: 622

More Releases from Coherent Market Insights

Imortant Facts about Global Cryptocurrency ATM Market You Should Know | Leading …
Cryptocurrency ATMs are the easiest means to buy cryptocurrencies, which also support selling of the digital currencies. Owing to their capability to support multiple forms of cryptocurrencies and ability to support any national currencies across the globe, these machines have gained significant traction over the past few years. Prominent growth factor fueling demand is the proliferation of these digital assets or currencies, across the globe and growing acceptance of these
Making Potential Expansion Prospects In The Cognitive Systems Market
The cognitive system is a suit of technologies, which extracts the insights form the structured and unstructured data by using machine learning and natural language processing technology. The increasing unstructured data, such as call center transcripts, documents, email messages, social media content, and social networking sites contents has become one of the major factors for the growth of the cognitive system market. For instance, approximately 300 million photos are uploaded
A Comprehensive Study Explore How Global Outdoor LED Display Market Will Grow In …
The global outdoor LED display market is projected to reach over US$ 40 billion by 2025, exhibiting a CAGR of 9.56% over the forecast period (2017 to 2025). The Outdoor LED display market is primarily driven by the innovation and modernization offered by LED lighting systems over incandescent and fluorescent lamps. Additionally, the energy efficiency of LED lights, longer lifetime, HD resolution, good pixel, enhanced physical strength, smaller size, design
Virtual and Augmented Reality Market To Exhibit Skyrocketing Expansion with Blip …
The market report envelopes all-in information on the global Virtual and Augmented Reality Market and the nature of the market growth over the foreseeable period. The report provides a comprehensive elaboration of the positives and negatives of the global Virtual and Augmented Reality market with Regression Analysis, S.T.E.E.P.L.E and Porter's Five Forces Analysis. With SWOT analysis, the report offers detailed insights about different players operating within the Virtual and Augmented

All 5 Releases


More Releases for Cathepsin

Cathepsin K Inhibitors Therapeutics Pipeline Analysis 2019
Cathepsin K is a protease enzyme which is coded by CTSK gene. The function associated with the gene involves bone remodelling and resorption. Cathepsin K is a member of peptidase C1 protein family and expressed mainly in osteoclasts. Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1176 The protein has high specificity for kinins and has the capability to catabolize collagen, elastin, and gelatin. Cathepsin K is found to be over-expressed in cancer such
Cathepsin Inhibitors Market Size, Growth and SWOT Analysis by Key Players F. Hof …
Cathepsins are a group of lysosomal proteases (enzymes that degrades protein), found in all animals and other organisms, and perform a key role in cellular protein turnover. Cathepsin family includes serine proteases, aspartic proteases, and cysteine proteases. The aspartyl protease class is composed of cathepsins D and E. The cysteine protease class comprises cathepsins B, L, H, K, S, and O. Cathepsin G includes serine protease class. Currently, there are
Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1)-Pipeline Revi …
A new report on “Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1)-Pipeline Review, H2 2017” offers information on the different clinical stages of Cathepsin B. The report, added to the vast repository of Market Research Hub (MRH) offers information and insights on the current scenario in development of Cathepsin B. A comprehensive source of information, the report provides detailed insights on the factors that are likely
Cathepsin S (CTSS or EC 3.4.22.27)-Pipeline Review, H2 2017: Market Insights, Em …
Presented study, Cathepsin S (CTSS or EC 3.4.22.27) pipeline Target constitutes close to 10 molecules. Out of which approximately 10 molecules are developed by Companies. The latest report Cathepsin S (CTSS or EC 3.4.22.27)-Pipeline Review, H2 2017, outlays comprehensive information on the Cathepsin S (CTSS or EC 3.4.22.27) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. Request Free
Cathepsin S (CTSS or EC 3.4.22.27) Market -Pipeline Review, H2 2017
"The Latest Research Report Cathepsin S (CTSS or EC 3.4.22.27)-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Cathepsin S Market Cathepsin S (CTSS or EC 3.4.22.27) pipeline Target constitutes close to 10 molecules. Out of which approximately 10 molecules are developed by Companies. The latest report Cathepsin S (CTSS or EC 3.4.22.27)-Pipeline Review, H2 2017, outlays comprehensive information
Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) Mar …
"The Latest Research Report Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15)-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Cathepsin L1 Market According to the recently published report 'Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15)-Pipeline Review, H2 2017'; Cathepsin L1 (Cathepsin L or Major Excreted Protein or